• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

SriniVas R. Sadda, MD, named 2023-2024 ARVO president-elect

Article

In his role as president elect, SriniVas Sadda, MD, will continue to serve on the board as well as begin planning for his term as president, which will kick off next May at the conclusion of ARVO’s 2024 Annual Meeting in Seattle, Washington.

(Image Credit: AdobeStock/eakgrungenerd)

(Image Credit: AdobeStock/eakgrungenerd)

SriniVas R. Sadda, MD, was named president-elect of the Association for Research in Vision and Ophthalmology (ARVO).

According to a news release from Doheny Eye Institute, where Sadda is the director of Artificial Intelligence & Imaging Research at Doheny Eye Institute and Professor of Ophthalmology at the University of California – Los Angeles (UCLA) David Geffen School of Medicine, Sadda has been a member of ARVO for a number of years and served on the Board of Trustees for the past 3 years.

In his role as president-elect, Sadda will continue to serve on the board as well as begin planning for his term as president, which will kick off next May at the conclusion of ARVO’s 2024 Annual Meeting in Seattle, Washington, according to a news release.

“We are eager to see Dr. Sadda step into his new role of ARVO President Elect, as he has already proven to be an integral member of our board over the last few years,” said J. Mark Petrash, PhD, executive vice president of ARVO. “His tremendous professional accomplishments in this field make him more than qualified for this position, and we are eager to see the impact of his leadership.”

SriniVas R. Sadda, MD (Image Credit: Doheny Eye Institute)

SriniVas R. Sadda, MD (Image Credit: Doheny Eye Institute)

According to the Doheny news release, Sadda’s major research interests include automated retinal image analysis, retinal substructure assessment, advanced retinal imaging technologies, and vision restoration approaches. His research has been consistently funded by the National Institutes of Health (NIH), multiple private organizations and industry, and he is considered an internationally-recognized expert on the retina.

“ARVO is a tremendously important organization to help further vision research and our understanding of the eye, with nearly 10,000 ARVO members worldwide actively working to understand, prevent and treat ocular diseases,” Sadda said in the news release. “Being selected to serve as President-Elect, and ultimately President in another year, is a tremendous honor and career highlight. I look forward to contributing even further to ARVO and advancing the possibilities for vision research.”

“This recognition for Dr. Sadda proves what many of us in the field already knew: that he is one of the most important retinal experts in the world,” Alfredo A. Sadun, MD, PhD, Flora Thornton Endowed Chair of Vision Research and Vice Chair and Professor of Ophthalmology at UCLA’s David Geffen School of Medicine, said in the news release. “I am confident he will bring great contributions to ARVO in his new role.”

More information about the ocular research being conducted at Doheny Eye Institute is available online.

Related Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Lorraine Provencher, MD, presenting slides
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.